Industry News
IRBM’s Advent announces the manufacturing of 13,000 COVID-19 vaccine doses
The first 4,000 doses have been delivered for use in the Phase 2/3 clinical trial COV002 by the University of Oxford
News & Articles
25
The first 4,000 doses have been delivered for use in the Phase 2/3 clinical trial COV002 by the University of Oxford